No connection

Search Results

DHX

NEUTRAL
$2.74 Live
DHI Group, Inc. · NYSE
Target $5.25 (+91.6%)
$1.21 52W Range $3.34

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 26, 2026
Market cap
$123.22M
P/E
N/A
ROE
-12.9%
Profit margin
-10.6%
Debt/Equity
0.18
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
80%
DHX exhibits a critically weak deterministic health profile with a Piotroski F-Score of 2/9, signaling significant fundamental deterioration. While the company maintains a strong gross margin (84.66%) and a low debt-to-equity ratio (0.18), it faces severe liquidity constraints evidenced by a current ratio of 0.44. Valuation metrics are attractive with a Price/Sales ratio under 1.0 and a reasonable forward P/E of 13.70, but these are offset by declining year-over-year revenue growth of -10.20%. The stock is a high-risk play where strong earnings beats and analyst optimism clash with deteriorating balance sheet health.

Key Strengths

Very high gross margins (84.66%) typical of scalable software models
Low long-term leverage with a Debt/Equity ratio of 0.18
Consistent history of beating earnings estimates with high surprise percentages
Attractive valuation with Price/Sales at 0.96 and Price/Book at 1.22
Positive year-over-year EPS growth (+28.6%) despite revenue declines

Key Risks

Severe liquidity risk indicated by a Current Ratio of 0.44 and Quick Ratio of 0.38
Negative revenue growth (-10.20% YoY) suggesting a shrinking market or loss of competitiveness
Weak fundamental health as evidenced by a Piotroski F-Score of 2/9
Negative net profit margins (-10.57%) and negative ROE (-12.94%)
Bearish technical trend (0/100) despite recent 1-year price appreciation
AI Fair Value Estimate
Based on comprehensive analysis
$3.85
+40.5% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
35
Weak
Value
70
Future
35
Past
50
Health
20
Dividend
0
AI Verdict
Speculative Value Trap Risk
Key drivers: Critical liquidity shortage, Revenue contraction, Deep valuation discount, Strong earnings surprise track record
Confidence
85%
Value
70/100

Trades at a significant discount to analyst targets ($5.25) and historical software multiples.

Positives
  • P/S < 1.0
  • Forward P/E of 13.70 is modest for tech
Watchpoints
  • Negative profit margins
  • Lack of Graham Number due to negative earnings
Future
35/100

Growth is currently driven by cost-cutting/efficiency rather than top-line expansion.

Positives
  • EPS growth is positive
  • Analyst target price suggests 91% upside
Watchpoints
  • Revenue growth is negative both YoY and Q/Q
  • PEG ratio of 1.56 is mediocre
Past
50/100

Recent price momentum contradicts long-term value destruction.

Positives
  • Strong 1-year recovery (+74.5%)
  • Consistent earnings beats over 25 quarters
Watchpoints
  • 5-year return is negative (-10.5%)
  • Long-term trend has been stagnant or declining
Health
20/100

The company is fundamentally fragile despite low long-term debt.

Positives
  • Low Debt/Equity ratio
Watchpoints
  • Piotroski F-Score of 2/9 is very weak
  • Current ratio (0.44) indicates inability to cover short-term liabilities
Dividend
0/100

Not a dividend-paying security.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$2.74
Analyst Target
$5.25
Upside/Downside
+91.6%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for DHX and closest competitors.

Updated 2026-04-24
DHX
DHI Group, Inc.
Primary
5Y
-10.5%
3Y
-28.5%
1Y
+74.5%
6M
+31.1%
1M
+2.6%
1W
-10.2%
SCO
comScore, Inc.
Peer
5Y
-87.5%
3Y
-61.8%
1Y
+62.0%
6M
+10.1%
1M
+12.5%
1W
+9.0%
REK
Rekor Systems, Inc.
Peer
5Y
-95.5%
3Y
-21.9%
1Y
+6.6%
6M
-72.2%
1M
-1.3%
1W
+17.3%
GOA
Eva Live, Inc.
Peer
5Y
-47.8%
3Y
-47.8%
1Y
-47.8%
6M
-47.8%
1M
-7.9%
1W
-7.7%
GPR
GoPro, Inc.
Peer
5Y
-93.5%
3Y
-83.9%
1Y
+59.6%
6M
-61.2%
1M
+1.0%
1W
-0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
13.7
PEG Ratio
1.56
P/B Ratio
1.22
P/S Ratio
0.96
EV/Revenue
1.33
EV/EBITDA
5.95
Market Cap
$123.22M

Profitability

Profit margins and return metrics

Profit Margin -10.57%
Operating Margin 11.52%
Gross Margin 84.66%
ROE -12.94%
ROA 4.3%

Growth

Revenue and earnings growth rates

Revenue Growth -10.2%
Earnings Growth N/A
Q/Q Revenue Growth -9.8%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.18
Low debt
Current Ratio
0.44
Weak
Quick Ratio
0.38
Poor
Cash/Share
$0.14

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
85.5%
Op. Margin
16.1%
Net Margin
4.3%
Total Assets
$0.2B
Liabilities
$0.1B
Equity
$0.1B
Debt/Equity
0.99x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
79%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-05
$N/A
2026-02-04
$0.09
+63.6% surprise
2025-11-10
$0.09
+125.0% surprise
2025-08-06
$0.07
+600.0% surprise

Technology Sector Comparison

Comparing DHX against 542 companies in the Technology sector (46 bullish, 183 neutral, 313 bearish)
Return on Equity (ROE)
-12.94%
This Stock
vs
-35.44%
Sector Avg
-63.5% (Below Avg)
Profit Margin
-10.57%
This Stock
vs
-12.42%
Sector Avg
-14.9% (Weaker)
Debt to Equity
0.18
This Stock
vs
0.7
Sector Avg
-74.4% (Less Debt)
Revenue Growth
-10.2%
This Stock
vs
4573.41%
Sector Avg
-100.2% (Slower)
Current Ratio
0.44
This Stock
vs
3.64
Sector Avg
-87.8% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

ANDORA ELIZABETH
Officer
Stock Award
2026-02-23
90,000 shares
BILASH PAMELA
Officer
Stock Award
2026-01-27
19,597 shares
FARNSWORTH PAUL
Chief Technology Officer
Stock Award
2026-01-27
62,709 shares
CONNOLLY EDWARD JACK
Officer
Stock Award
2026-01-27
19,597 shares
SCHIPPERS GREGORY
Chief Financial Officer
Stock Award
2026-01-27
27,435 shares
SCHILDT ALEXANDER
Officer
Stock Award
2026-01-27
31,355 shares
ZEILE ARTHUR H
Chief Executive Officer
Stock Award
2026-01-27
195,967 shares
FARNSWORTH PAUL
Chief Technology Officer
Stock Award
2026-01-26
40,000 shares
CONNOLLY EDWARD JACK
Officer
Stock Award
2026-01-26
30,000 shares
SCHIPPERS GREGORY
Chief Financial Officer
Stock Award
2026-01-26
60,000 shares
SCHILDT ALEXANDER
Officer
Stock Award
2026-01-26
40,000 shares
ZEILE ARTHUR H
Chief Executive Officer
Stock Award
2026-01-26
200,000 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-06
DEF 14A
DEF 14A
2026-04-02

DHX filed a definitive proxy statement on April 2, 2026, providing shareholders with necessary information and voting materials for its upcoming annual meeting.

8-K
8-K
2026-03-02
8-K
8-K
2026-02-26

DHX filed an 8-K on February 26, 2026, likely to report its annual financial results.

8-K
8-K
2026-02-23

DHX likely reported its fourth-quarter and full-year financial results.

10-K
10-K
2026-02-12

DHX filed its 10-K on February 12, 2026, providing comprehensive disclosures on its business operations, financial condition, and results of operations. The filing includes dedicated sections for risk factors and management's discussion and analysis to inform investors of the company's current financial standing and potential operational threats.

8-K
8-K
2026-02-04

DHX filed an 8-K on February 4, 2026, likely to report its annual financial results or a material corporate update.

10-Q
10-Q
2025-11-10

DHX submitted its quarterly 10-Q filing on November 10, 2025. While the filing includes a section for Risk Factors under Item 1A, no specific financial highlights or detailed risk descriptions were provided in the available excerpt.

8-K
8-K
2025-11-10
8-K
8-K
2025-11-06

DHX filed an 8-K on November 6, 2025, likely to announce its quarterly financial results.

10-Q
10-Q
2025-08-06
8-K
8-K
2025-08-06
8-K
8-K
2025-06-23
8-K
8-K
2025-05-20
10-Q
10-Q
2025-05-12
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
3 analysts
Barrington Research
2026-03-20
Maintains
Outperform Outperform
Barrington Research
2026-03-03
Maintains
Outperform Outperform
Barrington Research
2026-02-06
Maintains
Outperform Outperform
Barrington Research
2026-02-05
Maintains
Outperform Outperform
Lake Street
2025-11-11
down
Buy Hold

Past News Coverage

Recent headlines mentioning DHX from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile